<div id="readability-page-1"><p>Carnegie Investment Counsel trimmed its position in shares of  Northrop Grumman Corporation (NYSE:NOC - Free Report) by 9.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor  owned 48,357 shares of the aerospace company's stock after selling 4,921 shares during the period. Carnegie Investment Counsel's holdings in Northrop Grumman were worth $24,178,000 at the end of the most recent reporting period.</p><div><p><span></span><span>Get <strong>Northrop Grumman</strong> alerts:</span></p></div><ul><li>The Top 3 AI-Focused Defense Stocks to Put on Your Radar</li></ul><p>A number of other large investors have also added to or reduced their stakes in the company. Capital Investment Advisors LLC boosted its stake in  Northrop Grumman by 1.0% during the 2nd quarter. Capital Investment Advisors LLC now owns 2,049 shares of the aerospace company's stock valued at $1,025,000 after acquiring an additional 20 shares during the last quarter.  Tyche Wealth Partners LLC boosted its stake in  Northrop Grumman by 2.5% during the 2nd quarter. Tyche Wealth Partners LLC now owns 830 shares of the aerospace company's stock valued at $415,000 after acquiring an additional 20 shares during the last quarter.  Princeton Global Asset Management LLC boosted its stake in  Northrop Grumman by 0.3% during the 2nd quarter. Princeton Global Asset Management LLC now owns 5,907 shares of the aerospace company's stock valued at $2,953,000 after acquiring an additional 20 shares during the last quarter.  Integrated Investment Consultants LLC boosted its stake in  Northrop Grumman by 3.9% during the 1st quarter. Integrated Investment Consultants LLC now owns 553 shares of the aerospace company's stock valued at $283,000 after acquiring an additional 21 shares during the last quarter.  Finally, Ameriflex Group Inc. boosted its stake in  Northrop Grumman by 3.6% during the 2nd quarter. Ameriflex Group Inc. now owns 611 shares of the aerospace company's stock valued at $301,000 after acquiring an additional 21 shares during the last quarter. 83.40% of the stock is owned by institutional investors and hedge funds. </p><h2>Northrop Grumman Stock Performance</h2><p>Northrop Grumman stock opened at $605.17 on Friday. The firm's 50 day simple moving average is $593.98 and its 200-day simple moving average is $539.83. The company has a market cap of $86.65 billion, a P/E ratio of 21.77, a price-to-earnings-growth ratio of 5.63 and a beta of 0.10. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.11 and a quick ratio of 0.93. Northrop Grumman Corporation has a fifty-two week low of $426.24 and a fifty-two week high of $640.90. </p><ul><li>5 Stocks to Buy in August With Tremendous Upside Potential</li></ul><p>Northrop Grumman (NYSE:NOC - Get Free Report) last released its earnings results on Tuesday, October 21st. The aerospace company reported $7.67 earnings per share for the quarter, topping the consensus estimate of $6.43 by $1.24. The business had revenue of $10.42 billion for the quarter, compared to the consensus estimate of $10.68 billion. Northrop Grumman had a net margin of 9.82% and a return on equity of 25.49%. The firm's quarterly revenue was up 4.3% compared to the same quarter last year. During the same period last year, the firm posted $7.00 earnings per share.  Northrop Grumman has set its FY 2025 guidance at 25.650-26.050 EPS. As a group, equities research analysts predict that  Northrop Grumman Corporation will post 28.05 EPS for the current year. </p><h2>Northrop Grumman Announces Dividend</h2><p>The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 17th. Shareholders of record on Tuesday, September 2nd were given a $2.31 dividend. This represents a $9.24 annualized dividend and a yield of 1.5%. The ex-dividend date of this dividend was Tuesday, September 2nd. Northrop Grumman's payout ratio is currently 33.24%. </p><h2>Wall Street Analysts Forecast Growth</h2><ul><li>Could Baker Hughes Be an Unlikely Winner in Drone Defense Boom?</li></ul><p>NOC has been the topic of a number of research analyst reports. Bank of America increased their price objective on shares of Northrop Grumman from $550.00 to $650.00 and gave the company a &#34;buy&#34; rating in a research note on Wednesday, July 23rd. JPMorgan Chase &amp; Co. raised their price target on shares of Northrop Grumman from $575.00 to $640.00 and gave the stock a &#34;neutral&#34; rating in a research report on Wednesday. Sanford C. Bernstein  set a $696.00 price target on shares of Northrop Grumman in a research report on Thursday. Deutsche Bank Aktiengesellschaft  set a $700.00 price target on shares of Northrop Grumman and gave the stock a &#34;buy&#34; rating in a research report on Wednesday, October 8th. Finally, BTIG Research raised their price target on shares of Northrop Grumman from $630.00 to $680.00 and gave the stock a &#34;buy&#34; rating in a research report on Wednesday. One research analyst  has rated the stock with a Strong Buy rating, eleven have given a Buy rating and six have given a Hold rating to the company. According to MarketBeat, Northrop Grumman  has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $642.73.</p><p><b>Get Our Latest Stock Report on NOC</b></p><h2>Northrop Grumman Profile</h2> (Free Report)<p>Northrop Grumman Corporation operates as an aerospace and defense technology company in the United States, Asia/Pacific, Europe, and internationally. The company's Aeronautics Systems segment designs, develops, manufactures, integrates, and sustains aircraft systems. This segment also offers unmanned autonomous aircraft systems, including high-altitude long-endurance strategic ISR systems and vertical take-off and landing tactical ISR systems; and strategic long-range strike aircraft, tactical fighter and air dominance aircraft, and airborne battle management and command and control systems.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Northrop Grumman</li><li>Stock Average Calculator      </li><li>UnitedHealth's Moment of Truth: 3 Bullish Signals to Watch For</li><li>Trading Stocks: RSI and Why it's Useful</li><li>Warner Bros. Bidding War Potential: How High Could WBD Shares Go?</li><li>Conference Calls and Individual Investors</li><li>Analysts Eye 30% Upside in Netflix After Q3 Earnings Crash</li></ul><p><strong>Want to see what other hedge funds are holding NOC?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Northrop Grumman Corporation (NYSE:NOC - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU5PQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU5PQw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Northrop Grumman Right Now?</h2><p>Before you consider Northrop Grumman, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Northrop Grumman wasn't on the list.</p><p>While Northrop Grumman currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Carnegie Investment Counsel reduced its stake in Northrop Grumman Corporation (NYSE:NOC) by 9.2% in Q2, now holding 48,357 shares valued at $24.18 million. Other investors, including Capital Investment Advisors and Tyche Wealth Partners, also adjusted their positions. Northrop Grumman's stock opened at $605.17, with a market cap of $86.65 billion. The company reported $7.67 EPS for the last quarter, exceeding estimates, and announced a quarterly dividend of $2.31. Analysts have set price targets ranging from $550 to $700 for the stock.</p>

Northrop Grumman Corporation $NOC Shares Sold by Carnegie Investment Counsel